Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when LianBio publishes a filing, an earnings call transcript or a press release.

Get LIANY alerts

About Adam Stone

Adam Stone is recorded as CEO at LianBio (LIANY) since December 16, 2023, Board Member at LianBio (LIANY) and Board Member at Solid Biosciences Inc. (SLDB). The newest filing on record that lists Adam Stone as Board Member at LianBio (LIANY) is dated April 19, 2023. The newest filing on record that lists Adam Stone as Board Member at Solid Biosciences Inc. (SLDB) is dated April 23, 2026. LianBio reported in an 8-K filed December 19, 2023 that Adam Stone was appointed Interim Chief Executive Officer, effective December 16, 2023. Solid Biosciences Inc. reported in an 8-K filed June 9, 2023 that Adam Stone was appointed Class II director, effective June 6, 2023. LianBio is classified in the Biotechnology industry within the Healthcare sector. Solid Biosciences Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LianBio includes Ehong Gu (CFO), Konstantin Poukalov (Board Member), Neil Kumar (Board Member) and 3 others.

“In connection with Dr. Wang's departure, effective December 16, 2023, the Board appointed Adam Stone, member of the Board, as Interim Chief Executive Officer of the Company, until his successor is appointed or his earlier death, resignation or removal.”
LianBio Form 8-K, filed December 19, 2023 · Read the filing
“The Company's stockholders elected Clare Kahn, Adam Koppel, Adam Stone and Lynne Sullivan as Class II directors to serve until the 2026 Annual Meeting of Stockholders, each director to hold office until his or her successor has been duly appointed and qualified.”
Solid Biosciences Inc. Form 8-K, filed June 9, 2023 · Read the filing

Affiliation history

Company network

LianBio

LIANY

Current role

Biotechnology · Healthcare

Board Member, CEO

2023-12-16–present

Leadership on record at LianBio

Leadership on record at Solid Biosciences Inc.

Recent activity